Nihal Mohamed, Ph.D. Michael A. Diefenbach, Ph.D. Mount Sinai School of Medicine Department of Urology & Oncological Sciences, New York

Size: px
Start display at page:

Download "Nihal Mohamed, Ph.D. Michael A. Diefenbach, Ph.D. Mount Sinai School of Medicine Department of Urology & Oncological Sciences, New York"

Transcription

1 Differences between African American and white men in worries and expectations about prostate cancer treatment, need for information, and decisional regret Nihal Mohamed, Ph.D. Michael A. Diefenbach, Ph.D. Mount Sinai School of Medicine Department of Urology & Oncological Sciences, New York

2 Overview Health disparity in prostate cancer & treatment Decisional difficulties & regret Fear of recurrence (FoR) Depressive symptoms Relationship between decisional difficulties, depressive symptoms, FoR, and regret among African American and white patients

3 Prostate Cancer 2008 Pr Ca is the most common cancer effecting men in US & Canada Incidence: 186,320 in US Mortality: 28,660 in US Prostate 25% Lung & bronchus 31% Lung & bronchus 15% Prostate 10% Colon & rectum 10% Colon & rectum 8% Urinary bladder 7% Pancreas 6% Melanoma of skin 5% Leukemia 4% Non-Hodgk lymphoma 5% 4% Kidney 3% Liver & intrahepatic bile duct Oral Cavity 3% Esophagus 4% Leukemia 3% Non-Hodgkin lymphoma 3% Pancreas 2% Urinary bladder 3% Kidney 3% All Other Sites 18% All other sites 21% ACS. Cancer Facts & Figures 2008; FACT SHEET: CANADIAN CANCER STATISTICS CANCER TRENDS ACROSS CANADA & IN BRITISH COLUMBIA

4 Treatment Options of Early stage Prostate Cancer Surgery: Open surgery Laparoscopic Robotic surgery Radiation Therapy: External Beam Radiation therapy Brachytherapy (i.e., Seed Implant) CyberKnife radiosurgery (i.e. Image-guided robotic radiosurgery system) Expectant Management (i.e., Watchful Waiting)?

5 Consequences of Treatment Choice Impaired QOL Sexual Dysfunction Urinary Dysfunction Bowel Dysfunction (Eton & Lepore, 2002; Diefenbach & Mohamed, 2007, 2008)

6 Why prostate cancer treatment decision is so difficult???? Lack of a standard care Contradictions in physicians advices Imperfect data from various studies on QOL (Eton & Lepore, 2002; Diefenbach & Mohamed, 2007)

7 Why prostate cancer treatment decision is so difficult? Trust in the H. C.system Medical Insurance SES Balancing potential benefits of a treatment with the likelihood of impaired QOL & health care burden

8 Health Disparities Health Disparities: Are differences in the incidence, prevalence, mortality and burden of disease and other adverse conditions that exist among specific populations groups in the US. (NIH, 2005) Occur when members of certain population groups do not enjoy the same health status as other groups. Disparities are often identified along racial and ethnic lines-show, [but] also extend beyond race and ethnicity. (NCI, 2005)

9 Health Disparity in Prostate Cancer & treatment African American men: do have the highest incidence rate for prostate cancer in the US are more likely to die of the disease are less likely to undergo radical prostatectomy are more likely to opt for WW than white men. NCI (2007). Cancer Health Disparities: Questions and Answers. On-line publication.

10 Health Disparity in Prostate Cancer & treatment NCI (2007). Cancer Health Disparities: Questions and Answers. On-line publication.

11 Health Disparity in Prostate Cancer & treatment NCI (2007). Cancer Health Disparities: Questions and Answers. On-line publication.

12 Cognitive factors affecting prostate cancer treatment decision (Diefenbach & Butz, 2003, Diefenbach & Mohamed, 2007, Diefenbach et al, 2008)

13 Study Questions Differences between blacks & whites in: Prostate cancer treatment Beliefs & expectations about treatment Decisional conflict and role preferences Differences between blacks & whites in: Decision-related outcomes (decisional regret, worries about recurrence, and depressive symptoms) Explore Patterns of associations among study outcomes, and Differences between blacks & whites in patters of associations among study outcomes

14 Study Outline & Referral Sources Physician referral Participant contacted Agree/Decline Participation Baseline Questionnaire 6 months Questionnaire 12 months Questionnaire 18 months Questionnaire 24 months Questionnaire 36 months Questionnaire. Reading St. Mary s North Penn. Pinnacle FCCC Paoli. Jeanes. Co. Delaware.

15 Participants Black White t test /Chi-square p N Age (M±SD) ± ± Marital status: married not married 68.4% 31.6% 84.4% 15.2% <= high school >= College 78.9% 21.1% 78.3% 21.7% Employment: employed Not employed 51.3% 48.7% 40.2% 59.8% Number of DRE s (M±SD) Number of PSA(M±SD) Gleason Score (M±SD) 1.67 ± ± ± ± ± ± Education:

16 Comprehensive Assessments Clinical Variables: Demographics, Medical History Sexual/Urinary Problems Information Sources Treatment Related Psychological Variables: Worry About Treatment Side Effects Distress and Worry about Treatment Decision and Regret Worries about Recurrence Control Preference Scale Treatment Variables: Treatment Questions (Effectiveness) Use of Second Opinions and Recommendations General Psychological Variables: Perceived Vulnerability Affect Scales (i.e., CES-D, RIES) Decisional regret (Brehaut, 2003) Coping (i.e.,mbss) Reasons for Choosing Treatment Quality of Life (i.e., FACT-P)

17 Treatment Related Psychological Variables & Measures Decisional Conflict: Decisional difficulty Need of time Need of information Decisional regret (Brehout & O Conner, 2003) Decision role preferences Control Preferences Scale (Degner et al, 1997) Surgery- and radiation-related beliefs (ad-hoc) Perceived risk and severity of disease (ad-hoc) Worries about cancer recurrence (ad-hoc) Depression scale (CESD; Radloff, 1977)

18 Study Questions Differences between blacks & whites in: Prostate cancer treatment Beliefs & expectations about treatment Decisional conflict and role preferences Differences between blacks & whites in: Decision-related outcomes (decisional regret, worries about recurrence, and depressive symptoms) Explore Patterns of associations among study outcomes, and Differences between blacks & whites in patters of associations among study outcomes

19 Differences between blacks and whites in prostate cancer treatment % Chi-square =.02, p =.99

20 Differences between blacks and whites in prostate cancer related beliefs at baseline Very much Mean * ** Not al all ** p <.01, * p <.05.

21 Differences between blacks and whites treatment-related beliefs at baseline Mean Very much * ** Not al all ** p <.01, * p <.05.

22 Differences between blacks and whites in treatment-related beliefs at baseline Very much Mean *** *** Not al all *** p <.001.

23 Differences between blacks and whites Decision-related beliefs at baseline & 6M Very much Baseline 6 Months Mean * * Not al all * p <.05.

24 Differences between blacks and whites in decision role preferences at baseline % Chi-square = 12.85, p <.01.

25 A. Summary No differences in treatments received by race. Compared to white men, black men: felt less informed about prostate cancer; have stronger beliefs about the severity of the disease; were more worried about surgery causing pain and not curing cancer; were more worried about radiation causing pain and a new cancer; and were more likely to prefer an active role in treatment decision making.

26 Study Questions Differences between blacks & whites in: Prostate cancer treatment Beliefs & expectations about treatment Decisional conflict and role preferences Differences between blacks & whites in: Decision-related outcomes (decisional regret, worries about recurrence, and depressive symptoms) Explore Patterns of associations among study outcomes, and Differences between blacks & whites in patters of associations among study outcomes

27 Results: Decisional regret among blacks and whites at 6M Very much * Not al all * p <.05.

28 Differences between blacks and whites in decisional regret by treatment at 6M Mean Very much Not al all All P <.10

29 Mean Differences between blacks and whites in worries about recurrence by treatment at 6M Very much Not al all F treatment (2, 148) = 4.65, p <.05, Eta-square =.06

30 Results: Depressive symptoms at baseline & 6M % Chi-square =.44, p >.50 Cliff A M, Macdonagh,R.P. Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners. BJUI 68:

31 Study Questions Differences between blacks & whites in: Prostate cancer treatment Beliefs & expectations about treatment Decisional conflict and role preferences Differences between blacks & whites in: Decision-related outcomes (decisional regret, worries about recurrence, and depressive symptoms) Explore Patterns of associations among study outcomes, and Differences between blacks & whites in patters of associations among study outcomes

32 Correlations among cognitive predictors and decision-related outcomes in all patients regardless of race Regret 6M Worries about recurrence 6M Depressive Symptoms 6M Informed about Pr Ca Severity of Pr Ca ***.169* Difficulty of decision ***.205* Need of more time.217**.160*.189* Need of more INFO.393*** *** p <.001, ** p <.01, * p <.05.

33 Differences among blacks & whites in Patterns of associations between decisional conflict and decision-related outcomes Decisional Conflict Beliefs & expectation

34 Associations between study outcomes among black patients depressive symptom. severity E difficulty regret E need of INFO need of time X2 (N =186, df = 12) =6.4, p =.89; NFI =.95, RMSEA =.01 worry E2

35 Associations between study outcomes among white patients depressive symptom. severity E difficulty regret E need of INFO need of time worry X2 (N =186, df = 12) =6.4, p =.89; NFI =.95, RMSEA =.01 E2

36 B. Summary Compared to white men, black men: were more likely to feel regretful about prostate cancer treatment decision. No differences in worries about recurrence and depressive symptoms by race. Among blacks & whites; higher perceived severity of disease was significantly associated with more frequent worries about recurrence. Among blacks; need of time to think about Pr Ca treatment options was significantly associated with stronger feelings of decisional regret.

37 Future Directions Need to: increase prostate cancer literacy of African American men wider implementation of available decisional aids & tools development of culturally tailored educational interventions, care, and training

38 The VCI-S Study on prostate Cancer

39 Thank you for your attention

40 The VCI-S Study on prostate Cancer

41 Results: Depressive Symptoms over time by race

42 Results: Depressive symptoms by treatment & race

43 Worries about cancer recurrence at 6M 2-item scale How worried are you that prostate cancer will recur? How worried are you that prostate cancer might spread? Not at all (1) (5) very much Inter-item correlation was r =.82 (p <.001).

44 Differences among blacks & whites in Patterns of associations among study outcomes

Epidemiology in Texas 2006 Annual Report. Cancer

Epidemiology in Texas 2006 Annual Report. Cancer Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer

More information

CANCER FACTS & FIGURES For African Americans

CANCER FACTS & FIGURES For African Americans CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5

More information

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people* What is the Impact of Cancer on African Americans in Indiana? Table 13. Burden of Cancer among African Americans Indiana, 2008 2012 Average number of cases per year Rate per 100,000 people* Number of cases

More information

Cancer Facts & Figures for African Americans

Cancer Facts & Figures for African Americans Cancer Facts & Figures for African Americans What is the Impact of Cancer on African Americans in Indiana? Table 12. Burden of Cancer among African Americans Indiana, 2004 2008 Average number of cases

More information

Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials

Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials Mary Beth Terry, PhD Department of Epidemiology Mailman School of Public Health Racial and Ethnic Disparities in

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited

More information

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk ADVICE TO

More information

PROSTATE CANCER Amit Gupta MD MPH

PROSTATE CANCER Amit Gupta MD MPH PROSTATE CANCER Amit Gupta MD MPH Depts. of Urology and Epidemiology Amit-Gupta-1@uiowa.edu dramitgupta@gmail.com Tel: 319-384-5251 OUTLINE PSA screening controversy How to use PSA more effectively Treatment

More information

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT Frequently-Asked Questions What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication of prostate cancer, is available to you if you want

More information

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Chris Johnson, Cancer Data Registry of Idaho NAACCR 2016 Annual Conference June 14, 2016 Concurrent

More information

Oncology 101. Cancer Basics

Oncology 101. Cancer Basics Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.

More information

B.S (Honor) Psychology. University of Khartoum, Sudan, Diploma Cancer Prevention. The National Cancer Institute, USA, 2006.

B.S (Honor) Psychology. University of Khartoum, Sudan, Diploma Cancer Prevention. The National Cancer Institute, USA, 2006. Nihal E. Mohamed Office Address: The Mount Sinai Hospital Mount Sinai School of Medicine Department of Urology One Gustave L Levy Place Box 1272 New York NY 10029-6574 Tel.: 212-741-8858 Fax: 212-879-3246

More information

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 Achieving 80% by 2018: Working Together Can Get Us There Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 1 Prostate 21% Lung & bronchus 14% Colon & rectum 8% Urinary bladder 7% Melanoma of skin

More information

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004 MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer

More information

Collection of Recorded Radiotherapy Seminars

Collection of Recorded Radiotherapy Seminars IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology

More information

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,

More information

HIGH MORTALITY AND POOR SURVIVAL OF MEN WITH PROSTATE CANCER IN RURAL AND REMOTE AUSTRALIA

HIGH MORTALITY AND POOR SURVIVAL OF MEN WITH PROSTATE CANCER IN RURAL AND REMOTE AUSTRALIA HIGH MORTALITY AND POOR SURVIVAL OF MEN WITH PROSTATE CANCER IN RURAL AND REMOTE AUSTRALIA The prostate is a small gland the size of a walnut which produces fluid to protect and lubricate the sperm It

More information

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012 The Cancer Burden in California Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012 Goals Introduce you to the California Cancer Registry (CCR) Provide an

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2014 334 Jefferson Avenue, Scranton,

More information

National Cancer Statistics in Korea, 2014

National Cancer Statistics in Korea, 2014 National Cancer Statistics in Korea, 2014 2016. 12. 20. Korea Central Cancer Registry Cancer Incidence in Korea, 2014 National Cancer Incidence, 2014 Trends in Cancer Incidence by Sex and Year * Dark colored

More information

Cancer A Superficial Introduction

Cancer A Superficial Introduction Cancer A Superficial Introduction Gabor Fichtinger, Queen s University Cancer some definitions Medical term: malignant neoplasm Class of diseases in which a group of cells display: uncontrolled growth

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator November 2018 334 Jefferson Avenue, Scranton,

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2017 334 Jefferson Avenue, Scranton,

More information

2016 Oncology Institute Annual Report

2016 Oncology Institute Annual Report 2016 Oncology Institute Annual Report Message from the Cancer Committee: On behalf of the Cancer Committee of The Methodist Hospitals, we are pleased to present to you our 2016 Oncology Institute Annual

More information

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA Presented by: Bryan Rettig, MS Nebraska Dept. of Health & Human Services Division of Public Health May 31, 2017 Nebraska Cancer Registry

More information

PROSTATE CANCER CONTENT CREATED BY. Learn more at

PROSTATE CANCER CONTENT CREATED BY. Learn more at PROSTATE CANCER CONTENT CREATED BY Learn more at www.health.harvard.edu TALK WITH YOUR DOCTOR Table of Contents Ask your doctor about screening and treatment options. WHAT IS PROSTATE CANCER? 4 WATCHFUL

More information

The Selenium and Vitamin E Prevention Trial

The Selenium and Vitamin E Prevention Trial The largest-ever-prostate cancer prevention trial is now underway. The study will include a total of 32,400 men and is sponsored by the National Cancer Institute and a network of researchers known as the

More information

Cancer in New Mexico 2014

Cancer in New Mexico 2014 Cancer in New Mexico 2014 Please contact us! Phone: 505-272-5541 E-Mail: info@nmtr.unm.edu http://som.unm.edu/nmtr/ TABLE OF CONTENTS Introduction... 1 New Cases of Cancer: Estimated Number of New Cancer

More information

Cancer Dispari,es in Indiana

Cancer Dispari,es in Indiana Cancer Dispari,es in Indiana Susan M. Rawl, PhD, RN, FAAHB, FAAN Professor, Indiana University School of Nursing Co- Leader, Cancer PrevenEon & Control Program Indiana University Simon Cancer Center Indiana

More information

Objectives. Introduction. Questions???? Basic Facts. More Questions??? Treatment Decision Making in Prostate Cancer: Choices, Chances and Challenges

Objectives. Introduction. Questions???? Basic Facts. More Questions??? Treatment Decision Making in Prostate Cancer: Choices, Chances and Challenges Treatment Decision Making in Prostate Cancer: Choices, Chances and Challenges Anne Katz, RN, PhD Mary Schoen, RN, MSN, MPH, ANP, OCN Objectives Describe treatment choices for men newly diagnosed with prostate

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Colorectal Cancer Screening December 5, 2017 Connecticut Cancer Partnership 14th Annual Meeting Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director, Cancer Genetics and Prevention Program

More information

Dr Sylvie Lambert, RN, PhD

Dr Sylvie Lambert, RN, PhD Is it the most frequent unmet supportive care needs that predict caregivers anxiety and depression? Results from Australia s Partners and Caregivers Longitudinal Well-being Study Dr Sylvie Lambert, RN,

More information

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer Cancer in Ontario 1 in 2 Ontarians will develop cancer in their lifetime 1 in 4 Ontarians will die from cancer 14 ONTARIO CANCER STATISTICS 2016 1 Cancer in Ontario An overview Cancer is a group of more

More information

Contemporary Approaches to Screening for Prostate Cancer

Contemporary Approaches to Screening for Prostate Cancer Contemporary Approaches to Screening for Prostate Cancer Gerald L. Andriole, MD Robert K. Royce Distinguished Professor Chief of Urologic Surgery Siteman Cancer Center Washington University School of Medicine

More information

AllinaHealthSystems 1

AllinaHealthSystems 1 2018 Dimensions in Oncology Genitourinary Cancer Disclosures I have no financial or commercial relationships relevant to this presentation. Matthew O Shaughnessy, MD, PhD Director of Urologic Oncology

More information

Prostate cancer. Treatments Side effects and management in the community setting

Prostate cancer. Treatments Side effects and management in the community setting Prostate cancer Treatments Side effects and management in the community setting Kristoffer Ohlin CNS Urology Janice Minter Lead Cancer Nurse St George s Hospital Agenda Prostate cancer treatments Radiotherapy

More information

Comprehensive cancer cover

Comprehensive cancer cover Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our

More information

Quality of Life After Modern Treatment Options for Prostate Cancer Ronald Chen, MD, MPH

Quality of Life After Modern Treatment Options for Prostate Cancer Ronald Chen, MD, MPH Quality of Life After Modern Treatment Options I will be presenting some recently published data on the quality of life after modern treatment options for prostate cancer. My name is Dr. Ronald Chen. I'm

More information

Bioengineering and World Health. Lecture Twelve

Bioengineering and World Health. Lecture Twelve Bioengineering and World Health Lecture Twelve Four Questions What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How

More information

Cancer in New Mexico 2017

Cancer in New Mexico 2017 Cancer in New Mexico 0 Please contact us! Phone: 0-- E-Mail: nmtr-info@salud.unm.edu URL: nmtrweb.unm.edu TABLE OF CONTENTS Introduction... New Cases of Cancer Estimated Number of New Cancer Cases Description

More information

Burden of Cancer in California

Burden of Cancer in California Burden of Cancer in California California Cancer Reporting and Epidemiologic Surveillance Institute for Population Health Improvement UC Davis Health August 22, 2018 Outline 1. Incidence and Mortality

More information

The Center for Prostate Care, ProHealth Care Regional Cancer Center, Wisconsin

The Center for Prostate Care, ProHealth Care Regional Cancer Center, Wisconsin The Center for Prostate Care, ProHealth Care Regional Cancer Center, Wisconsin A prostate care coordinator supports, educates, and guides patients through diagnosis, treatment, and follow-up by Don Jewler

More information

NEZ PERCE COUNTY CANCER PROFILE

NEZ PERCE COUNTY CANCER PROFILE NEZ PERCE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a

More information

KOOTENAI COUNTY CANCER PROFILE

KOOTENAI COUNTY CANCER PROFILE KOOTENAI COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a

More information

BOUNDARY COUNTY CANCER PROFILE

BOUNDARY COUNTY CANCER PROFILE BOUNDARY COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a

More information

Comprehensive cancer cover

Comprehensive cancer cover Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our

More information

Samuel M. Lesko, MD, MPH Director of Research/Medical Director

Samuel M. Lesko, MD, MPH Director of Research/Medical Director Cancer in Northeastern Pennsylvania: Incidence, Mortality and Survival for Common Cancers Samuel M. Lesko, MD, MPH Director of Research/Medical Director May 11 334 Jefferson Avenue, Scranton, PA 1851-57-941-7984

More information

ADAMS COUNTY CANCER PROFILE

ADAMS COUNTY CANCER PROFILE ADAMS COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a group

More information

BONNER COUNTY CANCER PROFILE

BONNER COUNTY CANCER PROFILE BONNER COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a group

More information

BINGHAM COUNTY CANCER PROFILE

BINGHAM COUNTY CANCER PROFILE BINGHAM COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group

More information

NICE BULLETIN Diagnosis & treatment of prostate cancer

NICE BULLETIN Diagnosis & treatment of prostate cancer Diagnosis & treatment of prostate cancer NICE provided the content for this booklet which is independent of any company or product advertised Diagnosis and treatment of prostate cancer Introduction In

More information

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional

More information

Consensus and Controversies in Cancer of Prostate BASIS FOR FURHTER STUDIES. Luis A. Linares MD FACRO Medical Director

Consensus and Controversies in Cancer of Prostate BASIS FOR FURHTER STUDIES. Luis A. Linares MD FACRO Medical Director BASIS FOR FURHTER STUDIES Main controversies In prostate Cancer: 1-Screening 2-Management Observation Surgery Standard Laparoscopic Robotic Radiation: (no discussion on Cryosurgery-RF etc.) Standard SBRT

More information

NEZ PERCE COUNTY CANCER PROFILE

NEZ PERCE COUNTY CANCER PROFILE NEZ PERCE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a

More information

KOOTENAI COUNTY CANCER PROFILE

KOOTENAI COUNTY CANCER PROFILE KOOTENAI COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a

More information

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients

More information

TWIN FALLS COUNTY CANCER PROFILE

TWIN FALLS COUNTY CANCER PROFILE TWIN FALLS COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is

More information

The Role Primary Care has in Reducing Prostate Cancer Disparities

The Role Primary Care has in Reducing Prostate Cancer Disparities The Role Primary Care has in Reducing Prostate Cancer Disparities Paul Monk Associate Professor Clinical Division of Medical Oncology Ohio State University Prostate Cancer Disparity Does it exist? Prostate

More information

About the authors Dr S. Larry Goldenberg Dr Tom Pickles Dr Kim N. Chi

About the authors Dr S. Larry Goldenberg Dr Tom Pickles Dr Kim N. Chi Authors S. Larry Goldenberg, CM, OBC, MD, FRCSC, FCAHS Professor and Head, University of British Columbia Department of Urologic Sciences, Stephen A. Jarislowski Chair in Urologic Sciences at Vancouver

More information

*

* Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The

More information

JEROME COUNTY CANCER PROFILE

JEROME COUNTY CANCER PROFILE JEROME COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group

More information

BUTTE COUNTY CANCER PROFILE

BUTTE COUNTY CANCER PROFILE BUTTE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group

More information

LINCOLN COUNTY CANCER PROFILE

LINCOLN COUNTY CANCER PROFILE LINCOLN COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group

More information

Locally advanced prostate cancer

Locally advanced prostate cancer Diagnosis Helpline 0800 074 8383 prostatecanceruk.org 1 Locally advanced prostate cancer In this fact sheet: What is locally advanced prostate cancer? What tests are used to diagnose locally advanced prostate

More information

CANYON COUNTY CANCER PROFILE

CANYON COUNTY CANCER PROFILE CANYON COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group

More information

Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer

Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer Preliminary Results from the National Program of Cancer Registries Patterns of Care Study (PoC1) NAACCR Annual Meeting

More information

Brachytherapy Treatment of Prostate Cancer: a Post- Operative Case Study

Brachytherapy Treatment of Prostate Cancer: a Post- Operative Case Study Brachytherapy Treatment of Prostate Cancer: a Post- Operative Case Study Kyle N. Dawson Freeport High School, Freeport NY USA 11520 Abstract. When prostate cancer is detected, a common and often successful

More information

NIH Public Access Author Manuscript Cancer. Author manuscript; available in PMC 2006 December 17.

NIH Public Access Author Manuscript Cancer. Author manuscript; available in PMC 2006 December 17. NIH Public Access Author Manuscript Published in final edited form as: Cancer. 2005 December 15; 104(12 Suppl): 2989 2998. 1999 2001 Cancer Mortality Rates for Asian and Pacific Islander Ethnic Groups

More information

THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES

THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES OVERVIEW Diagnosis Laboratory Tests PSA Free and Total PSA PCA-3 4K Score The

More information

Cancer Institute. cancer institute Program overview Report 2013

Cancer Institute. cancer institute Program overview Report 2013 Cancer Institute cancer institute Program overview Report 2013 Saint Francis Medical Center in Cape Girardeau, Mo., is a regional leader in the battle against cancer, bringing new techniques, ideas and

More information

Researching Genetic Influences in Different Racial/Ethnic Populations and Cancer

Researching Genetic Influences in Different Racial/Ethnic Populations and Cancer Researching Genetic Influences in Different Racial/Ethnic Populations and Cancer Lenora WM Loo, PhD Assistant Professor (Specialist) University of Hawaii Cancer Center Off-Label Use Disclosure I do not

More information

Robotic Surgery for Prostate Cancer: A Realistic Approach to Getting Started The Evolution of a Robotic Surgeon

Robotic Surgery for Prostate Cancer: A Realistic Approach to Getting Started The Evolution of a Robotic Surgeon Robotic Surgery for Prostate Cancer: A Realistic Approach to Getting Started The Evolution of a Robotic Surgeon Douglas S. Scherr, M.D. Clinical Director, Urologic Oncology Weill Medical College of Cornell

More information

Prostate Cancer Dashboard

Prostate Cancer Dashboard Process Risk Assessment Risk assessment: family history assessment of family history of prostate cancer Best Observed: 97 %1 ; Ideal Benchmark:100% measure P8 2 Process Appropriateness of Care Pre-treatment

More information

Cancer Disparities in Arkansas: An Uneven Distribution. Prepared by: Martha M. Phillips, PhD, MPH, MBA. For the Arkansas Cancer Coalition

Cancer Disparities in Arkansas: An Uneven Distribution. Prepared by: Martha M. Phillips, PhD, MPH, MBA. For the Arkansas Cancer Coalition Cancer Disparities in Arkansas: An Uneven Distribution Prepared by: Martha M. Phillips, PhD, MPH, MBA For the Arkansas Cancer Coalition Table of Contents Page Burden of Cancer 3 Cancer Disparities 3 Cost

More information

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014 Cancer in Rural Illinois, 1990-2010 Incidence, Mortality, Staging, and Access to Care April 2014 Prepared by Whitney E. Zahnd, MS Research Development Coordinator Center for Clinical Research Southern

More information

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected

More information

Prostate Overview Quiz

Prostate Overview Quiz Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the

More information

An Overview of Disparities Research in Access to Radiation Oncology Care

An Overview of Disparities Research in Access to Radiation Oncology Care An Overview of Disparities Research in Access to Radiation Oncology Care Shearwood McClelland III, M.D. Department of Radiation Medicine Oregon Health & Science University Portland, Oregon Disclosures

More information

Active surveillance for low-risk Prostate Cancer Compared with Immediate Treatment: A Canadian cost evaluation

Active surveillance for low-risk Prostate Cancer Compared with Immediate Treatment: A Canadian cost evaluation Active surveillance for low-risk Prostate Cancer Compared with Immediate Treatment: A Canadian cost evaluation Alice Dragomir, PhD Fabio Cury, MD Armen Aprikian, MD Introduction Clinical and economic burden

More information

Objectives. Men s Health in US. Gender as a determinant of health status. Gender and racial differences in life expectancy, US

Objectives. Men s Health in US. Gender as a determinant of health status. Gender and racial differences in life expectancy, US Objectives Determinants of Men s Health: Opportunities for Evidence-based intervention Jean G. Ford, M.D. Department of Epidemiology Johns Hopkins Bloomberg of Public Health Baltimore, MD Epidemiologic

More information

Jennifer Fournier, RN MSN AOCN CHPN on 6/16/2012 at Oncology Nursing Society

Jennifer Fournier, RN MSN AOCN CHPN on 6/16/2012 at Oncology Nursing Society SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,

More information

Public Reporting of Outcomes CANCERCARE CENTER

Public Reporting of Outcomes CANCERCARE CENTER Public Reporting of Outcomes CENTER Minot, North Dakota 206 TRINITY HEALTH STATISTICS 206 There are,790 cancer primaries in the Trinity Health cancer registry from 990 (assession year) through 206. This

More information

PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA

PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA CINA SURVIVAL Authors: Chris Johnson, Deborah Hurley, Angela Mariotto, Reda Wilson, Donna Turner, Hannah

More information

Improving Women s Health in South Carolina Best Chance Network and WISEWOMAN. Dr. Trenessa K. Jones Best Chance Network Program Director

Improving Women s Health in South Carolina Best Chance Network and WISEWOMAN. Dr. Trenessa K. Jones Best Chance Network Program Director Improving Women s Health in South Carolina Best Chance Network and WISEWOMAN Dr. Trenessa K. Jones Best Chance Network Program Director Presentation Objectives Overview the History and Need for the Best

More information

Mr PHIP No. 1 Prostate cancer: Should I be tested?

Mr PHIP No. 1 Prostate cancer: Should I be tested? Mr PHIP No. 1 cancer: Should I be tested? Having a large prostate doesn t increase your chances of having prostate cancer. No. 1 / 1 Key points cancer is the most common male cancer after skin cancer.

More information

RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK

RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK 02 April, 2018 RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK Document Filetype: PDF 501.52 KB 0 RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK If you have been diagnosed with prostate

More information

When to worry, when to test?

When to worry, when to test? Focus on CME at the University of Calgary Prostate Cancer: When to worry, when to test? Bryan J. Donnelly, MSc, MCh, FRCSI, FRCSC Presented at a Canadian College of Family Practitioner s conference (October

More information

Questions and Answers about Prostate Cancer Screening with the Prostate-Specific Antigen Test

Questions and Answers about Prostate Cancer Screening with the Prostate-Specific Antigen Test Questions and Answers about Prostate Cancer Screening with the Prostate-Specific Antigen Test About Cancer Care Ontario s recommendations for prostate-specific antigen (PSA) screening 1. What does Cancer

More information

Your Guide to Prostate Cancer

Your Guide to Prostate Cancer Your Guide to Prostate Cancer If you face a diagnosis of prostate cancer, what s next? We can help. A prostate cancer diagnosis can be overwhelming. The good news is that while prostate cancer can be serious,

More information

The Prostate Cancer Surgery Tick List. Use these questions as starters for your first meeting with your prostate cancer surgeon.

The Prostate Cancer Surgery Tick List. Use these questions as starters for your first meeting with your prostate cancer surgeon. The Prostate Cancer Surgery Tick List Use these questions as starters for your first meeting with your prostate cancer surgeon. Print these out and had to your doctor at the start of your meeting. Tick

More information

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD Understanding the risk of recurrence after primary treatment for prostate cancer Aditya Bagrodia, MD Aditya.bagrodia@utsouthwestern.edu 423-967-5848 Outline and objectives Prostate cancer demographics

More information

Prostate Cancer: from Beginning to End

Prostate Cancer: from Beginning to End Prostate Cancer: from Beginning to End Matthew D. Katz, M.D. Assistant Professor Urologic Oncology Robotic and Laparoscopic Surgery University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer

More information

Pros and Cons from the Patient Perspective in the Three Phases

Pros and Cons from the Patient Perspective in the Three Phases Pros and Cons from the Patient Perspective in the Three Phases Wanda M. Burdette, RN, OCN, CCRP Spartanburg Regional Medical Center SCOR NCORP November 6, 2015 12:00-2:00 PM CT Presentation Objectives

More information

Communities and Universities Working Together to Reduce Cancer Disparities Symposium 2005 UCLA

Communities and Universities Working Together to Reduce Cancer Disparities Symposium 2005 UCLA Communities and Universities Working Together to Reduce Cancer Disparities Symposium 2005 UCLA Marjorie Kagawa Singer, Ph.D., M.N., M.A., R.N. UCLA School of Public Health and Asian American Studies Center

More information

This report was made possible by Summit County Public Health s Cancer Concerns Assessment Team. Special thanks for their contribution and assistance

This report was made possible by Summit County Public Health s Cancer Concerns Assessment Team. Special thanks for their contribution and assistance This report was made possible by Summit County Public Health s Cancer Concerns Assessment Team. Special thanks for their contribution and assistance goes to: Stephanie Pike, MPH Public Health Specialist

More information

Screening and Diagnosis Prostate Cancer

Screening and Diagnosis Prostate Cancer Screening and Diagnosis Prostate Cancer Daniel Heng MD MPH FRCPC Chair, Genitourinary Tumor Group Tom Baker Cancer Center University of Calgary, Canada @DrDanielHeng Outline Screening Evidence Recommendations

More information

THE UROLOGY GROUP

THE UROLOGY GROUP THE UROLOGY GROUP www.urologygroupvirginia.com 1860 Town Center Drive Suite 150/160 Reston, VA 20190 703-480-0220 19415 Deerfield Avenue Suite 112 Leesburg, VA 20176 703-724-1195 224-D Cornwall Street,

More information

Cancer Statistics, 2008

Cancer Statistics, 2008 CA Cancer J Clin 8;58:71 96 Cancer Statistics, 8 Ahmedin Jemal, DVM, PhD; Rebecca Siegel, MPH; Elizabeth Ward, PhD; Yongping Hao, PhD; Jiaquan Xu*, MD; Taylor Murray; Michael J. Thun, MD, MS ABSTRACT Each

More information